Wondering if AstraZeneca at £152.30 is still offering value after a strong run, or if most of the easy gains are already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results